Region Hovedstadens Psykiatriske

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Schizophrenia3 trials
• Bipolar disorder1 trial
• Depression1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Region Hovedstadens Psykiatriske2 trials
• Boehringer Ingelheim International GmbH1 trial
• Bristol-Myers Squibb1 trial
• Jimmi Nielsen1 trial

Running trials

• Recruiting

  Acute Effects of Partial GABA(A)-Receptor Modulation by GT-002 on Psychophysiological Measures: The TOTEMS Phase II Clinical Trial Targeting Cognitive Impairment Associated with Schizophrenia

  2024-519389-28-00· Phase 2· Region Hovedstadens Psykiatriske· Source

• Recruiting

  A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  NCT06929273· Phase 3· Bristol-Myers Squibb· Source

• Active, not recruiting

  The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Trial

  2022-501428-45-00· Phase 3· Region Hovedstadens Psykiatriske· Source

• Recruiting

  Biomarkers in Clozapine-responding Schizophrenia

  NCT05316883· Phase 4· Jimmi Nielsen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia2 recruiting
• Bipolar disorder1 recruiting

Closed trials

• Completed

  A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study

  2024-511560-93-00· Phase 3· Boehringer Ingelheim International GmbH· Source